Ticker brief
CTY
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
5
authors 14d
5
crowd 14d
+0.19
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-10-09 → 2026-10-16 · now +0.23 (−1 bearish … +1 bullish)
Who spoke5
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @IPODave | B | -0.45 | 1 | +0.15 |
| @Optimalinvestme | C | -2.28 | 1 | +0.00 |
| @fwpharma | B | -1.91 | 1 | +0.20 |
| @harry03994688 | A | -0.16 | 1 | +0.15 |
| @LaMonicaBuzz | B | -1.79 | 1 | +0.35 |
Recent signals5of 5 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-16 | @LaMonicaBuzz | +0.35 | Notes two biotech IPOs performing well during risk-off sessions. | · | tweet ↗ |
| 2026-10-16 | @harry03994688 | +0.15 | Uses two large RNAi IPO financings and expanding indications to argue positively for Alnylam. | · | tweet ↗ |
| 2026-10-16 | @fwpharma | +0.20 | City raised $200M in an upsized IPO to advance RNAi therapies. | · | tweet ↗ |
| 2026-10-15 | @Optimalinvestme | +0.00 | Reports biotech issuer CTY is listing today with an $18 trading price. | · | tweet ↗ |
| 2026-10-09 | @IPODave | +0.15 | Says biotech dominates current IPO activity despite a sector bear market and may rebound. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.